Update on Epidemiology of and Preventive Strategies for Invasive Fungal Infections in Cancer Patients

Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study

(2014) Hsiang-Chi Kung et al.   Cancer Medicine

Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles

(2013) Jan W. M. van der Linden et al.   CLINICAL INFECTIOUS DISEASES

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

(2013) Barbara D. Alexander et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study

(2013) Russell E. Lewis et al.   MYCOSES

The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis

(2012) S P Georgiadou et al.   BONE MARROW TRANSPLANTATION

Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections

(2012) A.M. Nosari et al.   CLINICAL MICROBIOLOGY AND INFECTION

Human genetic susceptibility toCandidainfections

(2012) Theo S. Plantinga et al.   MEDICAL MYCOLOGY

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

(2011) David I. Marks et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer

(2011) Maria N. Chitasombat et al.   JOURNAL OF INFECTION

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

(2010) J. R. Wingard et al.   BLOOD

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

(2010) C. Cordonnier et al.   HAEMATOLOGICA

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT

(2008) H Hebart et al.   BONE MARROW TRANSPLANTATION

Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial

(2008) Bart J. Rijnders et al.   CLINICAL INFECTIOUS DISEASES

Toll-like Receptor 4 Polymorphisms and Aspergillosis in Stem-Cell Transplantation

(2008) Pierre-Yves Bochud et al.   NEW ENGLAND JOURNAL OF MEDICINE